Immunovant Market Cap 2019-2024 | IMVT

Immunovant market cap as of October 18, 2024 is $4.27B.

Immunovant market cap history and chart from 2019 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding.

Immunovant Market Cap 2019-2024 | IMVT

Immunovant market cap history and chart from 2019 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding.
Related Stocks
Company NameMarket
Cap
Amgen (AMGN)$172.8B
Vertex Pharmaceuticals (VRTX)$125.8B
Regeneron Pharmaceuticals (REGN)$111.1B
Bristol Myers Squibb (BMY)$108.2B
Gilead Sciences (GILD)$108B
CSL (CSLLY)$97B
GSK (GSK)$81.3B
Alnylam Pharmaceuticals (ALNY)$38.6B
Argenex SE (ARGX)$32.3B
BioNTech SE (BNTX)$28B
Biogen (BIIB)$27.5B
Illumina (ILMN)$22.9B
Moderna (MRNA)$22.1B
BeiGene (BGNE)$21.6B
Genmab (GMAB)$15B
BioMarin Pharmaceutical (BMRN)$13.3B
Insmed (INSM)$13.2B
Vaxcyte (PCVX)$13.2B
Exact Sciences (EXAS)$13B
Incyte (INCY)$12.7B
Sarepta Therapeutics (SRPT)$12B
Bio-Techne Corp (TECH)$11.4B
QIAGEN (QGEN)$9.9B
Bio-Rad Laboratories (BIO.B)$9.3B
Roivant Sciences (ROIV)$8.9B
Revolution Medicines (RVMD)$8.4B
Exelixis (EXEL)$8.4B
Intra-Cellular Therapies (ITCI)$8B
Legend Biotech (LEGN)$8B
Ascendis Pharma (ASND)$7.9B